Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNTech SE - ADR (BNTX) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance

BioNTech SE - ADRTrade
Citius Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

BioNTech SE - ADR vs Citius Pharmaceuticals Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: BioNTech SE - ADR is far larger — about 1164.9× Citius Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.

BNTXCTXR
Market Cap
$23.31B$20.01M
Sector
HealthHealth
52-Week High
$119.34$1.82
52-Week Low
$83.89$0.48
Enterprise Value
$6.60B$16.23M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR